SEARCH CATEGORY/COMPANY
SEARCH CATEGORY/COMPANY
The UAE pharmaceutical market has grown into one of the largest in the Middle East, drawing global manufacturers who rely on locally registered representative offices to manage regulatory submissions and market presence. As of 2025, the regulatory landscape shifted significantly: the newly created Emirates Drug Establishment (EDE) assumed 44 core pharmaceutical services previously handled by MOHAP, including marketing authorizations, import and export permits, GMP certification, and facility licensing for marketing offices. Foreign manufacturers cannot register products in the UAE without appointing a locally licensed representative, making the representative office structure a mandatory part of market entry.
A pharmaceutical representative office is the UAE-based branch of a foreign drug manufacturer or distributor, established to promote products, liaise with healthcare professionals, and manage regulatory documentation. It typically does not sell products directly but supports the manufacturer's local Marketing Authorization Holder (MAH) or Local Authorized Representative (LAR) in regulatory and commercial matters.
Offices acting as MAH handle product registration submissions, renewal filings, and post-approval lifecycle management with the EDE on behalf of the foreign manufacturer.
These offices coordinate with physicians, hospitals, and pharmacies to provide product information, clinical data, and pharmacovigilance support.
Representative offices linked to logistics or free zone operations coordinate import permits and distributor relationships across the UAE and wider GCC.
DCCIInfo currently lists 6 verified pharmaceutical representative office companies operating in Dubai, including offices linked to major international pharmaceutical groups. Given the regulatory complexity of this category following the 2025 MOHAP-to-EDE transition, DCCIInfo aims to serve as a comprehensive reference point for companies researching representative office setup in the UAE.
Companies planning a pharmaceutical representative office in the UAE should confirm whether their existing MOHAP registrations require realignment with EDE requirements, since renewals and new applications are now processed through the EDE portal rather than MOHAP.
A pharmaceutical representative office manages marketing, regulatory submissions, and physician liaison on behalf of a foreign drug manufacturer.
The Emirates Drug Establishment (EDE) now regulates most pharmaceutical marketing and facility licensing functions.
The EDE assumed 44 core pharmaceutical services from MOHAP effective 29 December 2025.
Yes, representative offices require appropriate licensing covering pharmaceutical marketing or facility activity.
A Marketing Authorization Holder is the locally licensed entity responsible for a foreign manufacturer's product registration.
Yes, all consumable medicinal and wellness products, including herbal and dietary supplements, require registration before market entry.
Facility site registration fees are commonly cited around 10,100 AED for first-time registration, covering application and processing charges.
© 2026 Digital Commercial Connect
Scroll
